½ÃÀ庸°í¼­
»óǰÄÚµå
1624484

½ÉÆó ¼Ò»ý¼ú(CPR) ÀåÄ¡ ½ÃÀå ±Ô¸ð : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ¹üÀ§ ¹× ¿¹Ãø

Cardiopulmonary Resuscitation Device Market Size By Type (Manual CPR Devices, Automated CPR Devices), By End-user (Hospitals, Pre-Hospital Care Settings, Ambulatory Surgical Centers), By Geographic Scope And Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2031³â±îÁöÀÇ CAGR ¼ºÀå·üÀº 13.42%·Î Àü¸ÁµÇ¸ç, 2031³â¿¡´Â 9¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. CPR ÀåÄ¡´Â ½ÉÁ¤Áö ȯÀÚ¿¡°Ô Èä°ñ ¾Ð¹ÚÀ» ½Ç½ÃÇϰí Áß¿äÇÑ Àå±â·ÎÀÇ Ç÷·ù¸¦ À¯ÁöÇϱâ À§ÇØ ÀÌ¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¼öµ¿ À¯Çü°ú ÀÚµ¿ À¯ÇüÀ¸·Î ºÐ·ùµÇ¾î °¢±â ´Ù¸¥ ½ÉÀå ºñ»ó »óȲÀÇ ½Ã³ª¸®¿À¸¦ Áö¿øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ´õ¿íÀÌ °©ÀÛ½º·¯¿î ½ÉÁ¤Áö ȯÀÚÀÇ »ýÁ¸À²°ú Àü±Í °³¼±¿¡ ÀÖ¾î CPR ÀåÄ¡ÀÇ Á߿伺Àº ÇコÄɾî ȯ°æÀ̳ª ±ä±Þ ´ëÀÀ »óȲ¿¡¼­ Á¡Á¡ ´õ Àνĵǰí ÀÖ½À´Ï´Ù.

½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå ¿ªÇÐ

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¿ø¿Ü½ÉÁ¤Áö(OHCA) ¹ß»ý·ü »ó½Â :

º´¿ø¿Ü ½ÉÁ¤Áö(OHCA) Áõ°¡´Â CPR ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ(AHA)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­¸¸ ¸Å³â 35¸¸ °Ç ÀÌ»óÀÇ OHCA ¿¡ÇǼҵ尡 ¹ß»ýÇϰí ÀÖÀ¸¸ç ±ä±Þ CPR °³ÀÔ ¾øÀÌ »ýÁ¸ È®·üÀº 12% ¹Ì¸¸ÀÔ´Ï´Ù. ½ÉÀå ÀÀ±ÞÀÇ Áõ°¡·Î ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â ÀÚµ¿ CPR ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Áúȯ(CVD)ÀÇ À¯º´·ü Áõ°¡ :

½ÉÇ÷°ü°è Áúȯ(CVDs)ÀÇ ¼¼°è ºÎ´ã Áõ°¡´Â CPR ÀåÄ¡ ¼ö¿ä¸¦ Áõ´ë½Ã۰í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é CVD·Î ÀÎÇÑ »ç¸ÁÀÚ´Â ¸Å³â 1,790¸¸ ¸íÀ¸·Î ¼¼°è »ç»óÀÚ ÃѼöÀÇ 32%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½ÉÁ¤Áö´Â CVDÀÇ °¡Àå ½É°¢ÇÑ ¿µÇâ Áß ÇϳªÀ̱⠶§¹®¿¡ À̵é ÁúȯÀÇ ¹ß»ý ºóµµ Áõ°¡·Î ÀÀ±Þ ¹× º´¿ø ¾çÂÊ È¯°æ¿¡¼­ CPR ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í °ø°ø Á¢±Ù Á¦¼¼µ¿ ÇÁ·Î±×·¥ :

Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í °ø°ø Á¢±Ù Á¦¼¼µ¿(PAD) ÇÁ·Î±×·¥ Áõ°¡°¡ CPR ±â±â ¾÷°è¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. À¯·´ ¼Ò»ý ÇùÀÇȸ(ERC)¿¡ µû¸£¸é À¯·´¿¡¼­´Â ¸Å³â 35¸¸ °ÇÀÇ °©ÀÛ½º·¯¿î ½ÉÁ¤Áö°¡ ¹ß»ýÇϰí ÀÖÀ¸¸ç »ýÁ¸À²À» Çâ»ó½Ã۱â À§ÇØ PAD ÇÁ·Î±×·¥ÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡°¡ °ø°øÀå¼Ò¿¡ Á¦¼¼µ¿±â ¼³Ä¡¸¦ ¹ýÁ¦È­Çϰí ÀÖ¾î CPR ÀåÄ¡, ƯÈ÷ CPR ±â´ÉÀÌ ÀÖ´Â ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â(AED)ÀÇ ¼ö¿ä¸¦ ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä °úÁ¦

ÀÚµ¿ CPR ÀåÄ¡ÀÇ ³ôÀº ºñ¿ë :

ÀÚµ¿ CPR ÀåÄ¡¿¡´Â ¸¹Àº ºñ¿ëÀÌ µé±â ¶§¹®¿¡ ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­´Â º¸±Þ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· :

¸¹Àº Áö¿ª¿¡¼­ °í±Þ CPR ÀåÄ¡ÀÇ ÀûÀýÇÑ »ç¿ë¹ýÀ» ±³À°¹ÞÀº ÀÇ·á Àü¹®°¡°¡ ºÎÁ·ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÎÁ·ÀÌ ÀÌ·¯ÇÑ ±â±âÀÇ È¿°úÀûÀÎ ÀÌ¿ëÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä µ¿Çâ

CPR ÀåÄ¡¿¡¼­ AI¿Í IoTÀÇ ÅëÇÕ :

CPR ÀåÄ¡¿¡ ´ëÇÑ ÀΰøÁö´É(AI)°ú »ç¹°ÀÎÅͳÝ(IoT) ±â¼úÀÇ ÅëÇÕÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ¼Ò»ý Ȱµ¿ ÁßÀÇ µð¹ÙÀ̽º ¼º´É, µ¥ÀÌÅÍ ¼öÁý, ½Ç½Ã°£ Çǵå¹éÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.

ÈÞ´ë¿ë ¹× °¡º­¿î ÀåÄ¡ÀÇ Á߿伺 :

È޴뼺ÀÌ ¶Ù¾î³ª°í °æ·®ÀÎ CPR ÀåÄ¡ÀÇ °³¹ß·ÎÀÇ ½ÃÇÁÆ®°¡ ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀÇ ¹è°æ¿¡´Â, ÈÞ´ë°¡ ¿ëÀÌÇÏ°í ±ä±Þ½Ã¿¡ ½Å¼ÓÇÏ°Ô ¹èÄ¡ÇÒ ¼ö ÀÖ´Ù°í ÇÏ´Â ¿ä±¸°¡ ÀÖ½À´Ï´Ù.

º´¿ø ÀÌ¿ÜÀÇ È¯°æ¿¡¼­ ä¿ë Áõ°¡ :

½ºÆ÷Ã÷ ½Ã¼³, Çб³, °ø°ø Àå¼Ò µî º´¿ø ÀÌ¿ÜÀÇ È¯°æ¿¡¼­ÀÇ CPR ±â±âÀÇ Ã¤¿ë µ¿ÇâÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ È®´ë´Â ´Ù¾çÇÑ Áö¿ª ȯ°æ¿¡¼­ÀÇ ±ä±Þ ´ëÀÀ ´É·ÂÀ» Çâ»ó½ÃŰ´Â ´ëóÀÇ ÀÏȯÀÔ´Ï´Ù.

½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀåÀÇ Áö¿ª ºÐ¼®

ºÏ¹Ì

ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È CPR ÀåÄ¡ ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÀå ¹ßÀÛ°ú ½ÉÁ¤Áö¸¦ Æ÷ÇÔÇÑ ½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ À¯º´·ü Áõ°¡´Â ºÏ¹Ì CPR ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø ¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ(AHA)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 2021³â ¾à 697,000¸íÀÌ ½ÉÀ庴À¸·Î »ç¸ÁÇßÀ¸¸ç, »ç¸ÁÀÚ ¼öÀÇ °ÅÀÇ 5¸í Áß 1¸íÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ CVD ºÎ´ãÀÌ Å©´Ù º¸´Ï ÀÀ±ÞÀÇ·á ÇöÀå¿¡¼­´Â ±¸¸í CPR ÀåÄ¡ ¼ö¿ä°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

½ÉÆó ¼Ò»ý°ú ±ä±Þ ´ëÀÀ°ú °ü·ÃµÈ ÀÏ¹Ý ½Ã¹ÎÀÇ ÀÇ½Ä Çâ»ó Ä·ÆäÀΰú ÈÆ·Ã ÇÁ·Î±×·¥ Áõ°¡°¡ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ 35¸¸ °Ç ÀÌ»óÀÇ ¿ø¿Ü½ÉÁ¤Áö°¡ ¹ß»ýÇϰí ÀÖÀ¸¸ç CPRÀ» Áï½Ã ½ÃÇàÇÏ¸é »ýÁ¸À²ÀÌ 2¹è ¶Ç´Â 3¹è°¡ µÈ´Ù°í º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀ̽ºÅÄ´õ CPRÀ» ÃËÁøÇÏ´Â Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê´Â °ø°ø °ø°£ ¹× º´¿ø¿¡¼­ ÀÚµ¿ CPR ÀåÄ¡ÀÇ Ã¤ÅÃÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ß´ÞÇϰí ÀÖÀ¸¸ç ÀÀ±Þ ÀÇ·á ¼­ºñ½º(EMS)°¡ ³Î¸® º¸±ÞµÇ°í ÀÖ´Â °ÍÀÌ CPR ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. º¸°í¼­¿¡ µû¸£¸é 2022³â ¹Ì±¹¿¡¼­ °í¿ëµÈ ÀÀ±ÞÀÇ·á±â»ç(EMT)¿Í ÀÀ±Þ±¸Á¶»ç´Â 26¸¸ 2,000¸íÀÌ ³Ñ½À´Ï´Ù. ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡¿Í °íµµÀÇ ÀÇ·á ±â¼úÀ» ÀÌ¿ë °¡´ÉÇÑ °ÍÀÌ, º´¿ø ÀüÀ̳ª º´¿ø¿¡¼­ÀÇ È¿À²ÀûÀÎ CPR ÀåÄ¡ÀÇ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

À¯·´

À¯·´ÀÇ CPR ÀåÄ¡ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü°è ÁúȯÀº ¿©ÀüÈ÷ À¯·´ÀÇ ÁÖ¿ä »çÀÎÀ̸ç, ÀÀ±ÞÀÇ·á¿¡ À־ CPR ÀåÄ¡ÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. À¯·´½ÉÀ庴ÇÐȸ(European Society of Cardiology : ESC)¿¡ µû¸£¸é À¯·´¿¡¼­´Â ¸Å³â 400¸¸¸í ÀÌ»óÀÌ CVD¿¡ ±âÀÎÇØ »ç¸ÁÇϰí ÀÖÀ¸¸ç À¯·´ ´ë·ú Àüü »ç¸ÁÀÇ 45%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ½ÉÇ÷°ü°è À̺¥Æ®ÀÇ ºÎ´ãÀÌ Å©±â ¶§¹®¿¡ º´¿ø°ú º´¿ø ¾Õ ¸ðµÎ ȯ°æ¿¡¼­ ½ÉÆó¼Ò»ý¼úÀ» »ç¿ëÇØ¾ß ÇÕ´Ï´Ù.

À¯·´¿¡¼­´Â ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â(AED)ÀÇ ¼³Ä¡³ª CPR Æ®·¹ÀÌ´×ÀÇ ÃßÁøÀ» Æ÷ÇÔÇÑ °ø°ø ¾×¼¼½º Á¦¼¼µ¿(PAD) ÇÁ·Î±×·¥ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯·´ ¼Ò»ý ÇùÀÇȸ(ERC)ÀÇ º¸°í¿¡ ÀÇÇϸé, À¯·´¿¡¼­´Â ¿¬°£ 35¸¸°Ç ÀÌ»óÀÇ ¿ø¿Ü½ÉÁ¤Áö°¡ ¹ß»ýÇϰí ÀÖ¾î PAD ÇÁ·Î±×·¥Àº »ýÁ¸À²ÀÇ Çâ»ó¿¡ ºÒ°¡°áÇÑ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌó·³ ¹ÙÀ̽ºÅÄ´õ CPR°ú AED¿¡ ´ëÇÑ Á¢±ÙÀÌ Áß½ÃµÇ°Ô µÈ °ÍÀÌ CPR ÀåÄ¡ÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í Á¶Á÷È­µÈ ÀÀ±Þ ÀÇ·á ¼­ºñ½º(EMS) ½Ã½ºÅÛÀº CPR ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. Verified Market Research¿¡ ÀÇÇϸé, EU¿¡´Â EMS ¿ä¿øÀ» Æ÷ÇÔÇÑ 290¸¸¸íÀÇ ÇコÄɾî Àü¹®°¡°¡ ÀÖ¾î ½ÉÀå ±ä±Þ»çÅ¿¡ ´ëÇÑ ½Å¼ÓÇÑ ´ëÀÀÀ» º¸ÁõÇϰí ÀÖ½À´Ï´Ù. °íµµÀÇ ÇコÄÉ¾î ½Ã½ºÅÛ°ú ÈÆ·ÃÀ» ¹ÞÀº ÀÎÀç°¡ ÀÌ¿ë °¡´ÉÇÑ °ÍÀÌ, º´¿øÀ̳ª ±¸±Þ ÇöÀå¿¡ À־ÀÇ °íǰÁúÀÇ CPR ÀåÄ¡ÀÇ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : ¼­¹®

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • ÀüÁ¦Á¶°Ç

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå °ËÁõµÈ ½ÃÀå Á¶»çÀÇ Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • ¹ë¸®µ¥À̼Ç
  • 1Â÷ ÀÚ·á
  • µ¥ÀÌÅÍ ¼Ò½º À϶÷

Á¦4Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : ÀåÄ¡ À¯Çüº°

  • °³¿ä
  • ±â°è½Ä ÇǽºÅæ ÀåÄ¡
  • ´Éµ¿Àû ¾Ð¹Ú °¨¾Ð(ACD) ÀåÄ¡
  • ÀÓÇÇ´ø½º ÀÓ°èÄ¡ ÀåÄ¡
  • ºÎÇÏ ºÐ»ê ¹êµå CPR ¶Ç´Â º£½ºÆ® CPR
  • ÈÞ´ë¿ë ÀåÄ¡¿¡ ÀÇÇÑ Èä º¹ºÎ ´Ü°èÀû ¾Ð¹Ú °¨¾Ð CPR
  • ü¿Ü ¼ö¼ú
  • ħ½ÀÀû °ü·ù ÀåÄ¡

Á¦6Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : ¿ëµµº°

  • °³¿ä
  • ±¸±Þ ºÎ¹®
  • °ü»óµ¿¸Æ ¹× ÁýÁßÄ¡·á½Ç
  • Àå±â ÀÌ½Ä ½Ã¼³
  • Ç×°ø ±¸¸í À¯´Ö ¹× ÀÀ±Þ ±¸¸í»ç

Á¦7Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø ¹× Áø·á¼Ò
  • ½ÉÀå Ä«Å×ÅÍ °Ë»ç½Ç
  • Àå±â À̽ĽÇ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°è ±âŸ Áö¿ª
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ¼¼°èÀÇ ½ÉÆó ¼Ò»ý¼ú ÀåÄ¡ ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • °¢»ç ½ÃÀå ·©Å·
  • ÁÖ¿ä °³¹ß Àü·«

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ZOLL Medical Corporation
  • CPR Medical Devices, Inc
  • Medkm Healthcare
  • Medtronic
  • HMP
  • Zeal Medical Private Limited
  • Premier Medical Systems & Devices Private Limited
  • Health Care Needs
  • Summit Healthcare Private Limited.
  • Universe Surgical Equipment Co.

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ ÁÖ¿ä ¹ßÀü

  • Á¦Ç° Ãâ½Ã ¹× °³¹ß
  • ÇÕº´ ¹× Àμö
  • »ç¾÷ È®´ë
  • ÆÄÆ®³Ê½Ê ¹× Á¦ÈÞ

Á¦12Àå ºÎ·Ï

  • °ü·Ã Á¶»ç
AJY 25.01.24

Cardiopulmonary Resuscitation Device Market Size and Forecast

Cardiopulmonary Resuscitation (CPR) Device Market size was valued at USD 0.33 Billion in 2024 and is projected to reach USD 0.9 Billion by 2031, growing at a CAGR of 13.42 % from 2024 to 2031. CPR devices are utilized to perform chest compressions on patients experiencing cardiac arrest and to maintain blood flow to vital organs. These devices are categorized into manual and automated types, each designed to assist in different scenarios of cardiac emergencies. Furthermore, the importance of CPR devices in improving survival rates and outcomes for sudden cardiac arrest victims is increasingly recognized in healthcare settings and emergency response situations.

Cardiopulmonary Resuscitation Device Market Dynamics

The key market dynamics that are shaping the CPR device market are outlined below:

Key Market Drivers

Rising Incidence of Out-of-Hospital Cardiac Arrests (OHCA):

The growing number of out-of-hospital cardiac arrests (OHCA) is a key driver of the CPR device market. According to the American Heart Association (AHA), over 350,000 OHCA episodes occur each year in the United States alone, with a survival probability of less than 12% without urgent CPR intervention. The increasing number of cardiac emergencies is driving up demand for automated CPR devices to enhance patient outcomes.

Increasing Prevalence of Cardiovascular Diseases (CVDs):

The growing global burden of cardiovascular diseases (CVDs) is increasing the demand for CPR equipment. According to the World Health Organization (WHO), CVDs kill 17.9 million people each year, accounting for 32% of total global casualties. Because cardiac arrests are one of the most serious consequences of CVD, the increasing frequency of these diseases raises the demand for CPR devices in both emergency and hospital settings.

Government Initiatives and Public Access Defibrillation Programs:

Increasing government initiatives and public access defibrillation (PAD) programs are boosting the CPR device industry. According to the European Resuscitation Council (ERC), 350,000 sudden cardiac arrests occur each year in Europe, and PAD programs are adopted to improve survival rates. Many nations are legislating the installation of defibrillators in public locations, which is driving up demand for CPR equipment, particularly automated external defibrillators (AEDs) with CPR functionality.

Key Challenges

High Cost of Automated CPR Devices:

The significant cost associated with automated CPR devices is seen as a barrier to widespread adoption, particularly in resource-limited healthcare settings.

Lack of Skilled Professionals:

A shortage of healthcare professionals trained in the proper use of advanced CPR devices is observed in many regions. This shortage is hindering the effective utilization of these devices.

Key Trends

Integration of AI and IoT in CPR Devices:

The incorporation of artificial intelligence (AI) and Internet of Things (IoT) technologies in CPR devices are pursued. These integrations are aimed at improving device performance, data collection, and real-time feedback during resuscitation efforts.

Focus on Portable and Lightweight Devices:

A shift towards the development of more portable and lightweight CPR devices is noted. This trend is driven by the need for easy transportability and quick deployment in emergencies.

Increasing Adoption in Non-Hospital Settings:

A growing trend of CPR device adoption in non-hospital settings such as sports facilities, schools, and public places is observed. This expansion is part of efforts to improve emergency response capabilities in various community settings.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Cardiopulmonary Resuscitation Device Market Regional Analysis

A more detailed regional analysis of the CPR device market is provided below:

North America

The North American region is expected to dominate the CPR device market over the forecast period. The increasing prevalence of cardiovascular diseases (CVDs), including heart attacks and cardiac arrests, is a major driver of the CPR device market in North America. According to the American Heart Association (AHA), about 697,000 people in the U.S. died from heart disease in 2021, accounting for nearly 1 in every 5 deaths. This high burden of CVDs accelerates the demand for life-saving CPR devices in emergency care settings.

The increasing number of public awareness campaigns and training programs related to CPR and emergency response is driving the demand for CPR devices. The American Heart Association reports that over 350,000 out-of-hospital cardiac arrests occur annually in the U.S. and immediate CPR doubles or triples survival rates. Government-supported initiatives to promote bystander CPR are encouraging the adoption of automated CPR devices in public spaces and hospitals.

North America's well-developed healthcare infrastructure and widespread access to emergency medical services (EMS) are key drivers for the CPR device market. According to a report, there were over 262,000 emergency medical technicians (EMTs) and paramedics employed in the U.S. in 2022. The availability of trained professionals and advanced medical technology enhances the demand for efficient CPR devices in pre-hospital and hospital settings.

Europe

The European market for CPR devices is anticipated to show significant growth during the forecast period. Cardiovascular diseases remain the leading cause of death in Europe, driving the demand for CPR devices in emergency medical care. According to the European Society of Cardiology (ESC), over 4 million deaths each year are attributed to CVDs in Europe, accounting for 45% of all deaths across the continent. This high burden of cardiovascular events necessitates the use of CPR devices in both hospital and pre-hospital settings.

Europe is witnessing a growing number of public access defibrillation (PAD) programs, which include the installation of automated external defibrillators (AEDs) and the promotion of CPR training. The European Resuscitation Council (ERC) reports that more than 350,000 out-of-hospital cardiac arrests occur annually in Europe, and PAD programs are becoming integral to improving survival rates. This growing emphasis on bystander CPR and AED accessibility boosts the adoption of CPR devices.

Europe's well-established healthcare infrastructure and organized emergency medical services (EMS) systems are key drivers for the CPR device market. According to Verified Market Research, there were 2.9 million healthcare professionals in the EU, including EMS personnel, ensuring quick response to cardiac emergencies. The availability of advanced healthcare systems and trained personnel fosters the demand for high-quality CPR devices in hospitals and emergency settings.

Cardiopulmonary Resuscitation Device Market: Segmentation Analysis

The Cardiopulmonary Resuscitation Device Market is segmented based on Type, End-user, and Geography.

Cardiopulmonary Resuscitation Device Market, By Type

  • Manual CPR Devices
  • Automated CPR Devices

Based on Type, Cardiopulmonary Resuscitation Device Market is classified into Manual CPR Devices and Automated CPR Devices. The automated CPR devices segment is expected to dominate the CPR device market. This dominance is attributed to several factors. The ability of automated devices to deliver consistent and high-quality chest compressions without fatigue is recognized. This capability is particularly valuable in prolonged resuscitation efforts. Automated CPR devices are seen as solutions to address the challenges of performing manual CPR in moving ambulances or during patient transport. The integration of advanced features such as real-time feedback and data recording in automated devices is appreciated. These features are contributing to improved resuscitation outcomes and post-event analysis.

Cardiopulmonary Resuscitation Device Market, By End-user

  • Hospitals
  • Pre-Hospital Care Settings
  • Ambulatory Surgical Centers
  • Others

Based on End-user, the cardiopulmonary resuscitation device market is classified into Hospitals, Pre-Hospital Care Settings, Ambulatory Surgical Centers, and Others. The hospital segment is anticipated to dominate the CPR device market. This dominance is explained by several factors. A higher frequency of cardiac arrest cases is handled in hospital settings, necessitating readily available and advanced CPR equipment. The financial capability of hospitals to invest in sophisticated medical devices, including automated CPR systems, is observed. A growing emphasis on improving in-hospital emergency response protocols is placed, leading to increased adoption of standardized CPR devices. The presence of trained medical professionals in hospitals who effectively operate advanced CPR devices is noted.

Cardiopulmonary Resuscitation Device Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on Geography, the cardiopulmonary resuscitation device market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region is expected to dominate the CPR device market during the forecast period. Cardiovascular diseases are highly prevalent in countries such as the United States and Canada. This region has a well-developed healthcare infrastructure that prioritizes emergency medical services. Early adoption of innovative medical technologies, such as sophisticated CPR equipment, is observed. Stringent regulatory criteria for medical devices and emergency care protocols are being introduced, increasing the demand for high-quality CPR equipment. Significant expenditures in healthcare R&D have been undertaken, as has the presence of important market competitors in the region.

Key Players

  • The "Cardiopulmonary Resuscitation Device Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Asahi Kasei Corporation, Stryker Corporation, Koninklijke Philips N.V., ZOLL Medical Corporation (Asahi Kasei Corporation), Physio-Control, Inc. (Stryker Corporation), Michigan Instruments, SCHILLER AG, CPR Medical Devices, Inc., Medtronic plc, and GE Healthcare.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Cardiopulmonary Resuscitation Device Market Recent Developments
  • In February 2023, ZOLL Medical Corporation announced the availability of a new automated CPR device with better real-time feedback capabilities. This gadget is intended to improve the effectiveness of chest compressions during resuscitation efforts.
  • In November 2022, Stryker Corporation developed a strategic agreement with a renowned provider of emergency medical services (EMS). This collaboration aims to increase the distribution of Stryker's CPR devices in pre-hospital care settings.
  • In August 2022, Physio-Control, Inc. announced the availability of compact and lightweight manual CPR equipment for use in restricted places. This gadget is intended to overcome the challenges of performing CPR in confined or difficult-to-access regions.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET, BY DEVICE TYPE

  • 5.1 Overview
  • 5.2 Mechanical Piston Device
  • 5.3 Active Compression-Decompression (ACD) Devices
  • 5.4 Impedance Threshold Device
  • 5.5 Load-Distributing Band CPR or Vest CPR
  • 5.6 Phased Thoracic-Abdominal Compression-Decompression CPR With a Hand-Held Device
  • 5.7 Extracorporeal Techniques
  • 5.8 Invasive Perfusion Devices

6 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Emergency Departments
  • 6.3 Coronary & Intensive Care Units
  • 6.4 Organ Transplant Facilities
  • 6.5 Air Medevac Units and EMT Rescue

7 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospital & Clinic
  • 7.3 Cardiac Catheterization Laboratories
  • 7.4 Organ Transplant Unit
  • 7.5 Others

8 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL CARDIOPULMONARY RESUSCITATION DEVICE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 ZOLL Medical Corporation
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 CPR Medical Devices, Inc
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Medkm Healthcare
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Medtronic
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 HMP
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Zeal Medical Private Limited
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Premier Medical Systems & Devices Private Limited
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Health Care Needs
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Summit Healthcare Private Limited.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Universe Surgical Equipment Co.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦